Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Page(s):  31-38

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 1
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 2
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 3
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 4
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 5
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 6
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 7
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Page 8

Download in electronic PDF format for $75

Abstract:  Intravenous admixture compounding is common practice in most hospitals throughout the world. In this intravenous admixture series, we are covering important and practical topics. This issue presents considerations related to ready-to-use products in preparing/compounding admixtures and in actually compounding ready-to-use preparations in the pharmacy for patient use; most compounded intravenous admixtures are ready-to-use for a specific patient. Considerations include room, refrigerated, and frozen ready-to-use, activated ready-to-use, compounding with ready-to-use, implementing a ready-to-use program, and examples of ready-to-use products, their composition, container size, and packaging.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, drug admixtures, intravenous infusion, parenteral ready to use products, premixed drug mixtures, sterile compounding, compounded sterile preparations, contamination control, diluents, stability, drug compatibility, packaging materials

Related Categories: CANCER AND AIDS, FORMULATIONS, ADVERSE DRUG EVENTS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, UROLOGY/URINARY TRACT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R
, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007
Pg. 426-432

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
Mar/Apr 2002
Pg. 120-122

Return to Top